2009
DOI: 10.1073/pnas.0903497106
|View full text |Cite
|
Sign up to set email alerts
|

Galectin-3 negatively regulates TCR-mediated CD4+T-cell activation at the immunological synapse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
131
0
2

Year Published

2009
2009
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 161 publications
(136 citation statements)
references
References 48 publications
3
131
0
2
Order By: Relevance
“…5A). It was reported that the lattice formed by Gal-3 negatively regulates the TCR response by restricting receptor lateral motility (23)(24)(25). These reports support the lack of costimulation in the presence of Gal-3, as well as its inhibitory effect on the Ag-specific T cell response.…”
Section: Gal-3 Antagonizes Ag-specific T Cell Responsesupporting
confidence: 69%
“…5A). It was reported that the lattice formed by Gal-3 negatively regulates the TCR response by restricting receptor lateral motility (23)(24)(25). These reports support the lack of costimulation in the presence of Gal-3, as well as its inhibitory effect on the Ag-specific T cell response.…”
Section: Gal-3 Antagonizes Ag-specific T Cell Responsesupporting
confidence: 69%
“…DEC-205 has been used to identify a population of tolerogenic DC specialized for the induction of Foxp3 1 Treg [27], and for the first time, we showed that a parasite product can increase the surface expression of the CLR DEC-205 directly on T cells. The upregulation of surface expression of galectin-3 is particularly interesting given the recent observation that galectin-3, recruited intracellularly to the immunological synapse, negatively regulates TCR-mediated CD4 1 T-cell activation [28]. Generation of Treg has been associated with suboptimal T-cell activation, resulting from antigen presentation by immature or sub-optimally primed DC [29,30].…”
Section: Discussionmentioning
confidence: 99%
“…However, under chronic conditions, galectin-3 appears to favor the resolution of inflammation, thus limiting tissue injury and promoting repair. In fact, it inhibits lipopolysaccharide-mediated inflammation [64], promotes T-cell apoptosis [65] and negatively regulates TCR-mediated T-cell activation [66,67]. Moreover, MacKinnon et al have shown that up-regulation of galectin-3 expression is a feature of the alternative macrophage (M2) phenotype and that release of galectin-3 by alternatively activated macrophages sustains the M2 phenotype contributing to some of its functions in vivo [68].…”
Section: Galectin-3 As a Disease Mediator: Animal Studiesmentioning
confidence: 99%